Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Solution structural model of the complex of the binding regions of human plasminogen with its M-protein receptor from Streptococcus pyogenes.

Yuan Y, Ayinuola YA, Singh D, Ayinuola O, Mayfield JA, Quek A, Whisstock JC, Law RHP, Lee SW, Ploplis VA, Castellino FJ.

J Struct Biol. 2019 Oct 1;208(1):18-29. doi: 10.1016/j.jsb.2019.07.005. Epub 2019 Jul 10.

PMID:
31301349
2.

Structure and Function Characterization of the a1a2 Motifs of Streptococcus pyogenes M Protein in Human Plasminogen Binding.

Quek AJH, Mazzitelli BA, Wu G, Leung EWW, Caradoc-Davies TT, Lloyd GJ, Jeevarajah D, Conroy PJ, Sanderson-Smith M, Yuan Y, Ayinuola YA, Castellino FJ, Whisstock JC, Law RHP.

J Mol Biol. 2019 Sep 6;431(19):3804-3813. doi: 10.1016/j.jmb.2019.07.003. Epub 2019 Jul 8.

PMID:
31295457
3.

Structural studies of plasmin inhibition.

Wu G, Quek AJ, Caradoc-Davies TT, Ekkel SM, Mazzitelli B, Whisstock JC, Law RHP.

Biochem Soc Trans. 2019 Apr 30;47(2):541-557. doi: 10.1042/BST20180211. Epub 2019 Mar 5. Review.

PMID:
30837322
4.

Tranexamic acid is an active site inhibitor of urokinase plasminogen activator.

Wu G, Mazzitelli BA, Quek AJ, Veldman MJ, Conroy PJ, Caradoc-Davies TT, Ooms LM, Tuck KL, Schoenecker JG, Whisstock JC, Law RHP.

Blood Adv. 2019 Mar 12;3(5):729-733. doi: 10.1182/bloodadvances.2018025429. No abstract available.

5.

Autoimmune Epilepsy: The Evolving Science of Neural Autoimmunity and Its Impact on Epilepsy Management.

Quek AML, O'Toole O.

Semin Neurol. 2018 Jun;38(3):290-302. doi: 10.1055/s-0038-1660860. Epub 2018 Jul 16. Review.

PMID:
30011410
6.

Chronic Manganese Toxicity Associated with Voltage-Gated Potassium Channel Complex Antibodies in a Relapsing Neuropsychiatric Disorder.

Ho CSH, Ho RCM, Quek AML.

Int J Environ Res Public Health. 2018 Apr 18;15(4). pii: E783. doi: 10.3390/ijerph15040783.

7.

X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors.

Law RHP, Wu G, Leung EWW, Hidaka K, Quek AJ, Caradoc-Davies TT, Jeevarajah D, Conroy PJ, Kirby NM, Norton RS, Tsuda Y, Whisstock JC.

Blood Adv. 2017 May 9;1(12):766-771. doi: 10.1182/bloodadvances.2016004150. eCollection 2017 May 9.

8.

Evaluation of Beer Fermentation with a Novel Yeast
Williopsis saturnus.

Liu SQ, Quek AY.

Food Technol Biotechnol. 2016 Dec;54(4):403-412. doi: 10.17113/ftb.54.04.16.4440.

9.

Stroke biomarkers in clinical practice: A critical appraisal.

Ng GJL, Quek AML, Cheung C, Arumugam TV, Seet RCS.

Neurochem Int. 2017 Jul;107:11-22. doi: 10.1016/j.neuint.2017.01.005. Epub 2017 Jan 11. Review.

PMID:
28088349
10.

Preferential Acquisition and Activation of Plasminogen Glycoform II by PAM Positive Group A Streptococcal Isolates.

De Oliveira DM, Law RH, Ly D, Cook SM, Quek AJ, McArthur JD, Whisstock JC, Sanderson-Smith ML.

Biochemistry. 2015 Jun 30;54(25):3960-8. doi: 10.1021/acs.biochem.5b00130. Epub 2015 Jun 18.

PMID:
26029848
11.

Intravenous immunoglobulin may reduce relapse frequency in neuromyelitis optica.

Viswanathan S, Wong AH, Quek AM, Yuki N.

J Neuroimmunol. 2015 May 15;282:92-6. doi: 10.1016/j.jneuroim.2015.03.021. Epub 2015 Mar 28.

PMID:
25903734
12.

Global stroke bill of rights.

Damrow J, Gaarder K, Chopra S, Scola G, Bourque K, Perez T, Perez M, Quek A; World Stroke Organisation.

Int J Stroke. 2014 Dec;9(8):964. doi: 10.1111/ijs.12399. No abstract available.

PMID:
25381685
13.

Dimerization is not a determining factor for functional high affinity human plasminogen binding by the group A streptococcal virulence factor PAM and is mediated by specific residues within the PAM a1a2 domain.

Bhattacharya S, Liang Z, Quek AJ, Ploplis VA, Law R, Castellino FJ.

J Biol Chem. 2014 Aug 1;289(31):21684-93. doi: 10.1074/jbc.M114.570218. Epub 2014 Jun 24.

14.

Acute-onset chronic inflammatory demyelinating polyneuropathy with focal segmental glomerulosclerosis.

Quek AM, Soon D, Chan YC, Thamboo TP, Yuki N.

J Neurol Sci. 2014 Jun 15;341(1-2):139-43. doi: 10.1016/j.jns.2014.03.040. Epub 2014 Mar 29.

PMID:
24726719
15.

Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy.

Toledano M, Britton JW, McKeon A, Shin C, Lennon VA, Quek AM, So E, Worrell GA, Cascino GD, Klein CJ, Lagerlund TD, Wirrell EC, Nickels KC, Pittock SJ.

Neurology. 2014 May 6;82(18):1578-86. doi: 10.1212/WNL.0000000000000383. Epub 2014 Apr 4.

16.

Does influenza A infection increase oxidative damage?

Ng MP, Lee JC, Loke WM, Yeo LL, Quek AM, Lim EC, Halliwell B, Seet RC.

Antioxid Redox Signal. 2014 Sep 1;21(7):1025-31. doi: 10.1089/ars.2014.5907. Epub 2014 Jul 21.

PMID:
24673169
17.

Does high-dose coenzyme Q10 improve oxidative damage and clinical outcomes in Parkinson's disease?

Seet RC, Lim EC, Tan JJ, Quek AM, Chow AW, Chong WL, Ng MP, Ong CN, Halliwell B.

Antioxid Redox Signal. 2014 Jul 10;21(2):211-7. doi: 10.1089/ars.2013.5801. Epub 2014 Feb 24.

PMID:
24410614
18.

Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis.

Jiao Y, Fryer JP, Lennon VA, McKeon A, Jenkins SM, Smith CY, Quek AM, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ.

JAMA Neurol. 2014 Jan;71(1):48-54. doi: 10.1001/jamaneurol.2013.5055.

19.

Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection.

Loke WM, Chow AY, Lam Mok Sing K, Lee CY, Halliwell B, Lim EC, Quek AM, Ooi EE, Seet RC.

Virol J. 2013 Oct 30;10:322. doi: 10.1186/1743-422X-10-322.

20.

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.

Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, McKeon A, Costanzi C, Iorio R, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ.

Neurology. 2013 Oct 1;81(14):1197-204. doi: 10.1212/WNL.0b013e3182a6cb5c. Epub 2013 Aug 30.

21.

MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis.

Kotsenas AL, Watson RE, Pittock SJ, Britton JW, Hoye SL, Quek AM, Shin C, Klein CJ.

AJNR Am J Neuroradiol. 2014 Jan;35(1):84-9. doi: 10.3174/ajnr.A3633. Epub 2013 Jul 18.

22.

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A, Pittock SJ.

JAMA Neurol. 2013 Feb;70(2):229-34. doi: 10.1001/jamaneurol.2013.592.

23.

Biomarkers of oxidative damage are elevated among individuals with high cardiovascular risk: refining subject selection strategies for antioxidant trials.

Seet RC, Quek AM, Lim EC, Halliwell B.

Free Radic Res. 2013 Apr;47(4):283-90. doi: 10.3109/10715762.2013.769215. Epub 2013 Feb 25.

PMID:
23343456
24.

Cyclooxygenase-1 mediated platelet reactivity in young male smokers.

Loke WM, Sing KL, Lee CY, Chong WL, Chew SE, Huang H, Looi WF, Quek AM, Lim EC, Seet RC.

Clin Appl Thromb Hemost. 2014 May;20(4):371-7. doi: 10.1177/1076029612466284. Epub 2012 Dec 14.

PMID:
23242413
25.

Thermogravimetric investigation of hydrochar-lignite co-combustion.

Liu Z, Quek A, Kent Hoekman S, Srinivasan MP, Balasubramanian R.

Bioresour Technol. 2012 Nov;123:646-52. doi: 10.1016/j.biortech.2012.06.063. Epub 2012 Jun 30. Erratum in: Bioresour Technol.2013 Apr;133:639-40.

PMID:
22960124
26.

Acute effects of cigarette smoking on insulin resistance and arterial stiffness in young adults.

Seet RC, Loke WM, Khoo CM, Chew SE, Chong WL, Quek AM, Lim EC, Halliwell B.

Atherosclerosis. 2012 Sep;224(1):195-200. doi: 10.1016/j.atherosclerosis.2012.06.060. Epub 2012 Jul 20.

PMID:
22840427
27.

The X-ray crystal structure of full-length human plasminogen.

Law RH, Caradoc-Davies T, Cowieson N, Horvath AJ, Quek AJ, Encarnacao JA, Steer D, Cowan A, Zhang Q, Lu BG, Pike RN, Smith AI, Coughlin PB, Whisstock JC.

Cell Rep. 2012 Mar 29;1(3):185-90. doi: 10.1016/j.celrep.2012.02.012. Epub 2012 Mar 8.

28.

Products of 5-lipoxygenase and myeloperoxidase activities are increased in young male cigarette smokers.

Loke WM, Lam KM, Chong WL, Chew SE, Quek AM, Lim ECh, Seet RC.

Free Radic Res. 2012 Oct;46(10):1230-7. doi: 10.3109/10715762.2012.701291. Epub 2012 Jul 4.

PMID:
22690830
29.

Effects of age and sex on aquaporin-4 autoimmunity.

Quek AM, McKeon A, Lennon VA, Mandrekar JN, Iorio R, Jiao Y, Costanzi C, Weinshenker BG, Wingerchuk DM, Lucchinetti CF, Shuster EA, Pittock SJ.

Arch Neurol. 2012 Aug;69(8):1039-43. doi: 10.1001/archneurol.2012.249.

30.

Autoimmune epilepsy: clinical characteristics and response to immunotherapy.

Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein C, Watson RE Jr, Kotsenas AL, Lagerlund TD, Cascino GD, Worrell GA, Wirrell EC, Nickels KC, Aksamit AJ, Noe KH, Pittock SJ.

Arch Neurol. 2012 May;69(5):582-93.

31.

Accurate targeting of botulinum toxin injections: how to and why.

Lim EC, Quek AM, Seet RC.

Parkinsonism Relat Disord. 2011 Nov;17 Suppl 1:S34-9. doi: 10.1016/j.parkreldis.2011.06.016. Review.

PMID:
21999895
32.

Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels.

Seet RC, Lee CY, Lim EC, Quek AM, Huang H, Huang SH, Looi WF, Long LH, Halliwell B.

Atherosclerosis. 2011 Nov;219(1):231-9. doi: 10.1016/j.atherosclerosis.2011.07.097. Epub 2011 Jul 26.

PMID:
21840002
33.

Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress?

Seet RC, Lee CY, Loke WM, Huang SH, Huang H, Looi WF, Chew ES, Quek AM, Lim EC, Halliwell B.

Free Radic Biol Med. 2011 Jun 15;50(12):1787-93. doi: 10.1016/j.freeradbiomed.2011.03.019. Epub 2011 Mar 17.

PMID:
21420490
34.

Removal of copper by oxygenated pyrolytic tire char: kinetics and mechanistic insights.

Quek A, Balasubramanian R.

J Colloid Interface Sci. 2011 Apr 1;356(1):203-10. doi: 10.1016/j.jcis.2010.12.025. Epub 2010 Dec 15.

PMID:
21266293
35.

Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome.

Seet RC, Lee CY, Lim EC, Quek AM, Huang SH, Khoo CM, Halliwell B.

Diabetes Care. 2010 May;33(5):1140-2. doi: 10.2337/dc09-2124. Epub 2010 Feb 25.

36.

Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.

Seet RC, Lee CY, Lim EC, Tan JJ, Quek AM, Chong WL, Looi WF, Huang SH, Wang H, Chan YH, Halliwell B.

Free Radic Biol Med. 2010 Feb 15;48(4):560-6. doi: 10.1016/j.freeradbiomed.2009.11.026. Epub 2009 Dec 4.

PMID:
19969070
37.

Low-energy and chemical-free activation of pyrolytic tire char and its adsorption characteristics.

Quek A, Balasubramanian R.

J Air Waste Manag Assoc. 2009 Jun;59(6):747-56.

PMID:
19603742
38.

Oxidative damage in dengue fever.

Seet RC, Lee CY, Lim EC, Quek AM, Yeo LL, Huang SH, Halliwell B.

Free Radic Biol Med. 2009 Aug 15;47(4):375-80. doi: 10.1016/j.freeradbiomed.2009.04.035. Epub 2009 May 7.

PMID:
19427377
39.

Can demographic and admission laboratory variables be useful to identify long-stay patients with acute ischemic stroke? A hospital-based cohort study in Singapore.

Seet RC, Lim EC, Chan YH, Chan BP, Quek AM, Ong BK.

Neurol Sci. 2009 Aug;30(4):275-80. doi: 10.1007/s10072-009-0084-0. Epub 2009 Apr 22.

PMID:
19387544
40.

Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study.

Seet RC, Chow AW, Quek AM, Chan YH, Lim EC.

Int J Infect Dis. 2009 Sep;13(5):e248-53. doi: 10.1016/j.ijid.2008.11.028. Epub 2009 Mar 3.

41.

Putting ethics on the spot in neurology.

Lim EC, Quek AM, Seet RC.

Nat Clin Pract Neurol. 2009 Mar;5(3):136-7. doi: 10.1038/ncpneuro1000. Epub 2009 Jan 27. No abstract available.

PMID:
19174773
42.

An algorithm for the kinetics of tire pyrolysis under different heating rates.

Quek A, Balasubramanian R.

J Hazard Mater. 2009 Jul 15;166(1):126-32. doi: 10.1016/j.jhazmat.2008.11.034. Epub 2008 Nov 21.

PMID:
19111984
43.

Take a bao if you are not superstitious.

Lim EC, Oh VM, Quek AM, Seet RC.

Ann Acad Med Singapore. 2007 Mar;36(3):217-20.

PMID:
17474184
44.

Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: pilot study.

Lim EC, Quek AM, Seet RC.

Neurol Neurophysiol Neurosci. 2006 Jun 30:4.

PMID:
17260081
45.
46.

Symptoms and risk factors of ocular complications following dengue infection.

Seet RC, Quek AM, Lim EC.

J Clin Virol. 2007 Feb;38(2):101-5. Epub 2006 Dec 4.

PMID:
17142099
47.

Post-infectious fatigue syndrome in dengue infection.

Seet RC, Quek AM, Lim EC.

J Clin Virol. 2007 Jan;38(1):1-6. Epub 2006 Nov 29.

PMID:
17137834
48.

Interesting in- and outpatient attendances at Hogwarts Infirmary and St Mungo's Hospital for magical maladies.

Lim EC, Pomfrey PM, Quek AM, Seet RC.

Ann Acad Med Singapore. 2006 Feb;35(2):127-9.

49.

Mycotic aneurysm due to Burkholderia pseudomallei infection: case reports and literature review.

Low JG, Quek AM, Sin YK, Ang BS.

Clin Infect Dis. 2005 Jan 1;40(1):193-8. Epub 2004 Dec 8. Review.

PMID:
15614712
50.

Membrane proteins stimulated by interferon-alpha in growth-inhibited, but not in resistant, Daudi cells.

Quek A, Goding J, Hoogenraad N.

Immunol Cell Biol. 1988 Oct-Dec;66 ( Pt 5-6):353-9.

PMID:
3224991

Supplemental Content

Support Center